SCHEMBL9895337

SCHEMBL9895337

Cc1cc(C(=O)OC2CCC(c3ccccc3O)CC2)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
SERPINE1 P05121 1/20 0.44
SCN1A P35498 2/20 0.42
SCN2A Q99250 2/20 0.42
SCN3A Q9NY46 2/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
HSD11B1 P28845 1/20 0.41
CYP2D6 P10635 1/20 0.40
TYR P14679 1/20 0.40
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA12 O43570 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
HCRTR2 O43614 1/20 0.36
HTR7 P34969 1/20 0.36
HTR3E A5X5Y0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9894847 0.89 SERPINE1 (0.52) TAS1R3TAS1R1SERPINE1SCN1ASCN2A
SCHEMBL9896453 0.85 SERPINE1 (0.43) SERPINE1SCN1ASCN2ASCN3AKMT2A
SCHEMBL9895419 0.81 TYR (0.47) TAS1R3TAS1R1SERPINE1SCN1ASCN2A
SCHEMBL17460977 0.81 SERPINE1 (0.46) TAS1R3TAS1R1SERPINE1SCN1ASCN2A
SCHEMBL9895339 0.81 SERPINE1 (0.46) TAS1R3TAS1R1SERPINE1SCN1ASCN2A
SCHEMBL9923602 0.81 SERPINE1 (0.46) TAS1R3TAS1R1SERPINE1SCN1ASCN2A
SCHEMBL17941264 0.80 STS (0.52) SERPINE1SCN1ASCN2ASCN3AKMT2A
SCHEMBL6450374 0.79 TYR (0.49) SERPINE1SCN1ASCN2ASCN3AKMT2A
SCHEMBL6450371 0.79 TYR (0.49) SERPINE1SCN1ASCN2ASCN3AKMT2A
SCHEMBL31574430 0.78 KMT2A (0.53) SERPINE1SCN1ASCN2ASCN3AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242948-B2 Diepoxy compound, process for producing same, and composition containing the diepoxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-01-26 US disclosed
EP-2474539-B1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND SUMITOMO CHEMICAL CO (JP) 2013-11-27 EP disclosed
EP-2474539-A1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2012-07-11 EP disclosed
US-20120149807-A1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149807-A1 DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND DHPS, DOHH, CYP19A1 TAS1R3 3595/4885TAS1R1 2979/4885SERPINE1 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.